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ABSTRACT 
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Fellows Advisor: Dr. Jack R. Nation 
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In contemporary North-American culture, two frequently combined drugs 
possessing abuse liability are cocaine and "ecstasy" (+/- 3, 4-methylenedioxy- 
methamphetamine [MDMA]). Each drug is a stimulant acting on brain dopamine sites, 
i. e. , cocaine acts to block reuptake of dopamine while ecstasy increases voltage-gated 
release of the neurotransmitter. With recurrent use, disturbances in dopamine regulation 
may alter the reward properties of these drugs when presented singularly or 
concurrently. Because an increasing number of drug abusers are female (currently, 
females comprise nearly one-third of the drug-abusing population), possible differential 
drug sensitivity in females has emerged as an issue and could affect treatment programs. 
This is the first study to test for behavioral alterations across gender with concurrent 
administration of these frequently abused drugs. It was hypothesized that elevated levels 
of extracellular dopamine associated with a combined exposure regimen would increase 
CPP relative to the case where each drug was administered alone, and it was predicted 
this effect would be amplified in females relative to males. Adult male and female rats 
received one of three doses of cocaine (0 mg/kg, 2. 5 mg/kg, 5 mg/kg) followed by 
MDMA (0 mg/kg, 5 mg/kg, 10 mg/kg) and were then tested in a CPP paradigm. 
Specifically, conditioned place preference (CPP), a commonly used model for studying 
the role of contextual cues in drug reward and drug-seeking, was employed in this 
investigation that sought to explore possible synergism between cocaine snd MDMA 
(ecstasy) in male and female rats. These results, however, suggest a biphasic effect of 
MDMA reward and a linear correlation between cocaine dose and reward properties. 
Concurrent administration displays antagonism of each drug. Females displayed less 
overall sensitivity than males except at the highest level of MDMA. This suggests that 
chronic drug abuse potential may vary according to both drug dose and gender. 
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CENDER-SPECIFIC MODULATION OF 
COCAINE-INDUCED PLACE PREFERENCE 
BY 3, 4-METHYLENEDIOXYMETHAMPHETAMINE 
INTRODUCTION 
Poly-drug abuse snd "being female" correlate with negative psychological 
experiences among MDMA users (Topp et al. , 1999). Though 3, 4- 
methylenedioxymethamphetamine (MDMA; "ecstasy") is an illegal substance, it is 
gaining global popularity as a recreational drug, especially in youth culture and at all- 
night dance parties called "raves. " The drug's increasing appeal may be attributable to 
positive subjective effects such as euphoria, mental stimulation, emotional tenderness, 
and decreased anxiety (Schenk et al. , 2003; Zhou et al. , 2003), which in humans are 
experienced concomitantly with MDMA use or within the first 24-hour period following 
drug exposure. Adverse psychological effects of MDMA such as severe depression, loss 
of appetite and cognitive impairment, which are attenuated by polydrug abuse and 
gender, were reported in humans more than 24-hours after taking the drug (Verheyden et 
al. , 2003). Positive effects and residual adverse effects of MDMA may reflect the initial 
rush of 5-HT (S-hydroxytryptamine, [serotonin]) followed by attenuation of 5-HT levels 
(Verheyden et al. , 2003). 
Drug effects neurochemically and behaviorally have been attributed primarily to 
the mesolimbic dopamine system, which runs from the venuul tegmental area to the 
nucleus accumbens (Higgins and Fletcher, 2003). Dopamine has been implicated as 
mediating the stimulatory effects of cocaine, which acts as a dopamine transport 
inhibitor (blocking reuptake and increasing dopamine availability at Dl and D2 
This thesis follows the style and format of 
Experimental and Clinical Psychopharmacology. 
postsynaptic receptors) (Riley, 1995). Cocaine and MDMA vary in the time onset of 
their observed effects. Cocaine simultaneously increases extracellular concentrations of 
serotonin and dopamine in contrast to MDMA, which causes an imtnediate increase of 
serotonin following injection and delayed extracellular increase of dopamine (White et 
al. , 1994). Rodent studies suggest that cocaine may enhance neurotoxic potential of 
MDMA by increasing dopamine release (Horan et al. , 2002; Fletcher et aL, 2001). 
Several studies additionally link drug potentiation to other neurotransmitter 
systems, which modify dopamine function or act independently of the dopaminergic 
system (Higgins and Fletcher, 2003; Bardo, 1998). Dopamine outside o f the nucleus 
accumbens can also affect drug reward mechanisms; for instance, increases in dopamine 
activity in the medial pre&ontal cortex (mPFC) have been linked with the reinforcing 
effects of cocaine in the conditioned place preference paradigm (Zavala et al. , 2003). 
Cocaine and MDMA both affect serotonin levels at the synapse. Though long 
associated with food reward, central serotonin centers similarly influence other reward- 
associated behaviors, especially those of drugs of abuse (Higgins and Fletcher, 2003). 
Serotonin has a role in motor control, pain perception, and sympathetic nervous system 
outflow. At the human level, excessive levels of serotonin can cause a multitude of 
symptoms commonly known as "Serotonin Syndrome" manifested as mental alterations 
such as confusion or agitation, autonomic changes such as hyperthermia and 
hypertension, and neuromuscular variations observable through muscle jerks and 
hyperactivity. Serotonin neurons innervate the dopaminergic system, which is 
associated with the rewarding and potentially addictive properties o f drug use. 
Mounting evidence indicates that activating some serotonin receptor subtypes facilitates 
dopamine effects (Slikker et al. , 1989). 
MDMA and cocaine both block reuptake transporters for serotonin, dopamine, 
and norepinephrine, acting, however, through different mechanisms (Slikker et al. , 
1989). Cocaine selectively inhibits reuptake transporters and increases serotonin release 
whereas MDMA inhibits monoamine oxidase (Leonardi k Azmitia, 1994), which 
increases synaptic levels of monoamines (serotonin and norepinephrine). MDMA acts 
primarily by stimulating the release of and successively blocking the reuptake of 
serotonin, thereby considerably amplifying the availability of the neurotransmitter in the 
synapse (Schenk et al. , 2003; White et al. , 1994). 
Increased levels of serotonin neurotransmitter coincides with a reduction in self- 
administration of cocaine and suggests a decrease in the drug's rewarding properties. In 
other instances, lowered serotonin neurotransmitter availability enhances drug-reward 
behavior. However, serotonin studies have not consistently defined the relationship 
between serotonin levels and drug-reward behavior (Higgins and Fletcher, 2003). 
In animals, at low doses (1-5 mg/kg), MDMA has limited neurotoxic potential 
and acts primarily as an indirect serotonin agonist (Zhou et al. , 2003). Additionally, 
MDMA administration also acts to increase synaptic levels of dopamine by directly 
inhibiting the dopamine transporter, which can act in addition to serotonin release 
(Schenk et aL 2003). Repeated or high dose (&20 mg/kg) administrations of MDMA to 
rats are neurotoxic to serotonin-containing axons (Green et al. , 1995). 
Serotonergic mechanisms have been suggested in behavioral effects of MDMA 
such as hyperactivity, as stimulus properties of MDMA generalized to serotonin agonists 
and some effects of MDMA were attenuated by prior administration of serotonin uptake 
inhibitors or pharmacological manipulations of serotonergic systems (I3ankston and 
Cunningham, 2002; Callaway et al. , 1990; Liechti and Vollenweider; 2000Schenk et al. , 
2003). Furthermore, recent studies with Rhesus monkeys implicate serotonergic 
mechanisms for MDMA's reward properties as pretreatment with the 5-HTs antagonist, 
ketanserin, decreased MDMA self-administration (Fantegrossi et al. 2002). Though 
MDMA has been implicated as a monoamine oxidase inhibitor responsible for 
decreasing serotonin metabolism, it also has been found to increase serotonin release. 
The lethality o f MDMA is attributed to its hyperthermic effect, an increase in 
core body temperature, that shortly follows hyperactivity. Unlike normal exercise- 
induced hyperthermia marked by increased cutaneous blood flow, MDMA contributes to 
hyperthermia by reducing cutaneous blood flow through vasoconstriction, diminishing 
normal heat transfer from the body to the environment. Further evidence of MDMA's 
ability to impair heat dissipation is seen in studies that report a failure of tail skin 
temperatures to increase. This hyperthermic effect also exacerbates dopainine 
neurotoxicity, Relatively small, physiologically relevant changes in temperature 
significantly lower dopamine transporter function. The hyperthermic effects of MDMA 
are dose-dependent, and cocaine also has the pmpensity to cause hyperthermia. Cocaine 
activates neuromuscular junctions to speed the body's metabolism, which increases heat 
production. This hyperthermic effect is seen most often in hot conditions, and may 
impair thermoregulatory adjustments that mediate heat dissipation; even small doses in 
humans have been shown to impair sweating snd dilation of cutaneous vessels as well as 
disrupting heat perception. This can be seen at levels as low as 2 mg/kg in rats. 
Both cocaine and MDMA have been demonstrated separately to possess abuse 
liability (Schenk et al. , 2003). Previous studies pre-exposed anunals to MDMA at a 
single dose and later tested them with CPP or self-administration. These studies exhibit 
lasting neurological alterations produced by repeated MDMA exposure as no MDMA 
was in the animals at the time of testing with cocaine (delay between MDMA exposure 
and CPP or self-administration study was longer than the half-life of MDMA). 
Consistent with concurrent polydrug abuse trends among rave attendees, this is the first 
study of its nature to test the behavioral effects of near-simultaneous exposure to both 
MDMA snd cocaine. 
The present research is also novel in its appraisal of the behavioral effects of 
cocaine and ecstasy between gender. Male rat studies have traditionally dominated areas 
of neuropscyhopharmacology research. However, women are comprising an 
increasingly larger percentage of the drug abusing population and rave participants. 
Reports indicated that of all reproductive-age women, approximately 10'/o engage in 
regular use of illegal drugs, 10'lo of which abuse cocaine (King et al. , 1990). A new 
push has been made to understand the perplexing differences seen in drug abuse patterns 
as well as differential responses to drug therapy between men and women. For instance, 
the patterns of cocaine abuse between men and women differ, wherein women 
experience an enhanced response and longer duration "high. " In rats, females exhibit 
increased hyperactivity afler cocaine exposure and develop self-administration behavior 
more quickly than do males (Zhou et al. , 2003). 
Bowman and Kuhn report that gender differences in cocaine responding emerge 
only after puberty, suggesting that ovarian hormones may influence the observed gender 
differences (1996). Additional studies show that hyperactivity following cocaine 
exposure is greater during proestrus and estrus (when estrogen and other ovarian 
hormones are highest) than during diestrus (Sell et al. , 2000), and when estrogen is 
administered to gonadectomized female mice (Chen et al. , 2003). Female rats implanted 
with 17p-estradiol exhibited greater locomotor hyperactivity following injections of both 
cocaine and (+)-MDMA than did ovariectomized females. The enhanced response to 
cocaine appeared within 5 nunutes following drug injection whereas the enhanced 
response to (+)-MDMA was delayed for approximately 30 minutes (Zhou et al. , 2003). 
These studies indicate that estrogen is a major contributor to gender differences in the 
behavioral response to cocaine and MDMA. Changes in estrogen hormone level cause 
variation in hyperactivity and dopamine release (Becker & Cha, 1989). 
Long-term cocaine abuse in humans can cause sexual dysfunction (Cocores et al. , 
1986) in addition to causing irregularities in the menstrual cycle by altering 
hypothalamic amine release (King et al. , 1990). Though female rats have regular, 4-day 
estrous cycles, within 7 days of cocaine exposure, female rats have shown repetitive 
days of estrous along with an absence of proestrus and enhanced periods of diestrus 
(King et al. , 1990). 
Previous animal models of drug potentiation have had profound implications 
with respect to defining drug abuse potential. Considerable evidence exists to 
demonstrate the importance of drug-related environmental stimuli in the reinforcing 
properties of drugs (Cervo et al. , 2002; Hoffinan et al. , 1989; Knapp et al. , 2002). An 
appropriate paradigm to study the influence of context on drug use is conditioned place 
preference (CPP). In this model, a drug is administered to the animal immediately 
before placement in an environment with unique contextual stimuli (olfactory, visual, 
tactile). Following alternating daily pairings of the drug with the unique context, and a 
distinctly different context with no drug (vehicle), the animal is tested for preference by 
being allowed I'ree-choice access to the drug-paired or the vehicle-paired context. Place 
preference is then defined by some measure of preference for one environment over 
another. Numerous drugs of abuse have been shown to produce a place preference, 
including cocaine and MDMA (Bardo et al. , 1995; HofIman et al. , 1989). 
While CPP is considered a valid model of drug reward and drug-seeking, it is 
further believed that augmentation in the development or expression of a CPP is a 
reflection of the enhancement of the neural mechanisms of drug reward. Conditioned 
place preference is commonly studied to ascertain a relative degree of reward and 
incentive motivation elicited by drugs and drug-paired stimuli (Zavala et al. , 2003). The 
CPP paradigm is based on classical (Pavlovian) conditioning principles, as contextual 
cues acquire secondary reinforcing properties through temporal pairing with the drug 
which functions as the unconditioned stimulus PJS] (Calcagnetti et al. , 1993). Polydrug 
abuse (e. g. , combined cocaine and MDMA) has been demonstrated to disrupt the 
acquisition of learned tasks (Block et al. , 2002), perhaps through modulation of neural 
loci associated with learning and potential cognitive impairments (Cory-Slechta, 1995; 
Lasley et al. , 1996). Thus, it is reasonable to suspect that any effects of xenobiotic 
substances on drug CPP may be due to alterations in learning and conditioning 
mechanisms. Moreover, mounting evidence indicates there may be pronounced gender 
differences in CPP to various drugs of abuse. 
The purpose of this research project was to characterize the dose-effect pattern 
produced by cocaine or MDMA in a CPP preparation, and more importantly to 
determine if synergism occurs when the two drugs are presented concurrently, as clinical 
consumption patterns verify (Block et al. , 2002; Gross et al. , 2002; Parry et al. , 2002; 
Smit et al. , 2002). In addition, gender (male, female) differences in drug responsiveness 
were assessed. 
MATERIALS AND METHODS 
Apparatus 
Place conditioning and testing were conducted in seven 20X60&&20 cm wooden 
shuttle boxes with wooden tilt floors. At each end of each box was a rnicroswitch 
interfaced to an IBM compatible computer. A BASIC computer program was written to 
continuously record the number of times and duration the switch was activated via a tilt 
of the floor. 
One compartment of the apparatus had smooth white walls and floor, and the 
other compartment had black walls with a black sandpaper floor. For conditioning 
sessions, the boxes were divided into two equal-sized compartments by removable 
partitions. On test sessions (pretest and posttest), the partitions were removed and a 
20x10x5 cm wooden platform was installed 2 cm above the floor to divide the two 
comparunents but allow flee access to either compartment by rats. In earlier 
investigations, subjects showed a strong preference for the black compartment (Miller et 
al. , 1999; Miller et al. , 2000; Miller and Nation, 1997; Smith and Nation, 2003). To 
counteract this preference, a 40 W light was positioned 50 cm above the black 
compartment of each apparatus. These seven lamps provided the only illumination in 
the testing room. Following each conditioning and test session the apparatus was 
cleaned with a mild soap solution. The apparatus was located in a sound-resistant room 
with a 40 dB white noise generator operating continuously. All conditioning and testing 
sessions were conducted during the light phase of the cycle. 
Drugs 
The Research Technology Branch of the National Institutes on Drug Abuse 
(NIDA) provided cocaine HCI and 3, 4-MDMA gratis. Cocaine HCI and MDMA HC1 
were dissolved in a 0. 9'/o w/v saline vehicle, and the doses were expressed as the salt. 
The (+)- isomer of MDMA was selected for this study because of its enhanced ability to 
produce hyperactivity relative to the (-)- isomer, and because it has been used 
extensively in similar studies. All cocaine was administered intraperitoneally (i. p. ) and 
all MDMA was administered subcutaneously (s. c. ) such that 1 mL/kg delivered the 
desired dose. 
Experiment 1: Male CPP 
Animals 
The animal housing and testing facility was approved by the Association for 
Assessment and Accreditation of Laboratory Animal Care International (AAALAC 
International, and all animal maintenance and research design and administration was 
conducted in accordance with guidelines provided by the University Laboratory Animal 
Care Committee (ULACC). All aspects of the research followed the guidelines outlined 
in Principles of Laboratory Animal Care (NIH Publication No. 85 — 23). The health of 
the animals was monitored by the campus veterinarian throughout the duration of the 
project. 
Adult male Sprague-Dawley rats (n = 63), weighing approximately 250 - 300g at 
the start of the experiment, were obtained Irom a commercial source (Harlan, Houston, 
TX). All animals were provided rat chow and tap water ad libitum throughout the 
course of the experiment, and were housed individually in plastic cages throughout the 
study. A 12h/12h light-dark cycle was used thmughout the study. Beginning one week 
prior to the start of the experiment, animals were handled daily to limit any confounding 
variables caused by handling stress during the conditioning or experimental procedures. 
Procedures 
The present study involved a biased conditioning pmcedure. Body weights were 
recorded daily throughout the experiment. CPP experiment was started following one 
week of accliination to the laboratory environinent. On day 1 of the CPP 
experiment, 
animals were transferred trom the colony room to the testing 
chambers for 20 minutes in 
an effort to habituate the animals to transportation and the 
sound and illumination of the 
room. Animals were placed in the apparatus an allowed tree 
access between 
compartments during the 20 minute period to overcome 6eezing 
effects from exposure 
to a novel environment. Data recorded trom the first day 
was not used in calculating 
preferred side. On day 2, animals were placed in the CPP apparatus 
and allowed iree 
access to either compartment for 15 minutes. Pretest data were 
measured by the amount 
of time animals spent in each compartment, and these data were used to 
determine 
animals' pretest preference for the white or the black compartment. 
On four alternate days (days 3, 5, 7, and 9), each animal received a daily 
subcutaneous injection of MDMA (0, 5, or 10 mg/kg body weight) 25 minutes 
before an 
intraperitoneal cocaine injection (0, 2. 5, or 5 mg/kg body weight). The time delay 
between MDMA and cocaine injections was based on the slow onset of the physiological 
effects of ecstasy (see above). The resulting interaction of 3 doses of MDMA x 3 
doses 
of cocaine created 9 groups for each gender experiment; OC (0 mg/kg cocaine) 
— OM (0 
mg/kg MDMA) (n = 7), 0 C - 5M (n = 7), OC — 10M (n 
= 7), 2, 5C — OM (n = 7), 2. 5C- 
5M(n=7), 2. 5C — 10M (n=7), SC — OM(n=7), 5C — 5M(n=7), and5C 
— 10M(n= 
7). See Table 1 below. 
Table 1: Drug Conditions. For both males and females, three doses of cocaine 
were 
interacted with 3 doses of MDMA creating 9 conditions of drug exposure, 
each 
containing 7 rats, n=63 per gender experiment. 
MDMA 
0 COC-OMDMA 0 COC-5 MDMA 0 COC-10MDMA 
Cocaine 2. 5 COC -0MDMA 2. 5 COC - 5 MDMA 2. 5 COC 
- 10MDMA 
5COC-OMDMA 5COC-5MDMA 5COC-10MDMA 
10 
Animals were confined to the least-preferred compartment (defined as the 
compartment in which the animal spent less amount of time on the day 2 pretest) for 20 
minutes immediately after injection of cocaine and/or MDMA. On the other four 
alternate days (days 4, 6, 8, and 10), all animals received a daily i. p. vehicle (saline) 
injection and were confined to the most-preferred compartment (defined as the 
compartment in which the animal spent more amount of time on the day 2 pretest) for 20 
minutes immediately after injection. All injecfions were given at a volume of 1 ml/kg. 
Animals were run in squads of seven, counterbalanced by group assignments. On day 
11, posttest data were obtained using the same procedure as the day 2 pretest; in the 
absence of an injection, subjects were perinitted free access between the cambers. 
Weight-sensitive flooring in the place preference apparatus recorded the amount of time 
spent in each chamber in addition to the frequency of threshold crossings. 
Experiment 2: Female CPP 
Animals 
Adult female Sprague-Dawley rats (n = 63), weighing approximately 250-300g at 
the start of the experiment, were obtained from a commercial source (Harlan, Houston, 
TX). All animals were provided rat chow and tap water ad libitum throughout the 
course of the experiment, and were housed individually in plastic cages throughout the 
study. A 12h/12h light-dark cycle was used throughout the study. Beginning one week 
prior to the start of the experiment, animals were handled daily to limit any confounding 
variables caused by handling stress during the conditioning or experimental procedures. 
Procedures 
The procedure for Experiment 2 was precisely as described for Experiment 1, 
with the following exceptions. To lessen the likelihood that all female rats (upon 
inatching their estrus cycles before or during the course of the experiment) would 
experience confounds with increased estrogen during drug exposure or testing days 
female animals were allowed 10 days of acclimation to the laboratory environment 
before starting in the CPP environment. The reproductive cycles of female huinans and 
animals living in close contact frequently align so their estrus cycles are occurring 
simultaneously. Because we had no way to determine which stage of the estrous cycle 
female rats were on without introducing unwanted stress, we had to counterbalance our 
testing days with the possibility that all or some of the female rats would be cycling 
together. To accomplish this, we staggered CPP start days so that 1/3 of the animals (3 
squads of 7 animals each, total n=21) began testing on each one of three consecutive 
days. Animals in each squad (n=7) were randomly chosen trom each drug exposure 
condition (see Table 1 for drug conditions) so that in the event of estrous cycle 
synchronization, rats in the same condition would still be receiving drug or vehicle 
injections on alternate days of the estrous cycle. This randomized drug exposure 
schedule decreased the likelihood that sensitivity to CPP or to cocaine and/or MDMA 
trom estrous would cause alterations in data trends. Thus, randomizing conditions to 
have slightly altered experiment schedules eliminated estrous as a possible confounding 
variable to CPP. Varying start days permitted the combination of all data and the 
observation of gender-based (not estrogen-based) trends by limiting possible 
confounding variables attributed the synchronization of the ovulatory cycle with 
presentation of cocaine and/or ecstasy. 
Females were vaginally lavaged immediately following the final test run and on 
the following three days, for a total of 4 consecutive samples of vaginal cells (the estrous 
cycle in rats is only 4 days), This was necessary to ensure that drug exposure and 
preference testing in each of the 9 drug conditions was indeed counterbalanced. 
Micmscope slides were stained and scored for estrous. 
Although drugs of abuse, e. g. cocaine, have been shown to disrupt estrous 
cycles in females (King, et. al. 1990), the vaginal lavage procedure itself has been shown 
to create a CPP (Walker et al. , 2002). The additional stress caused by vaginal lavage 
12 
could not have been equilibrated across gender, and would thus 
have presented a 
potential confound for comparisons between males and females if performed prior 
to or 
during the course of the experiment and data collection. All other aspects of the 
study 
proceded as described on Experiment 1. 
Statistical Analysis 
The pretest data &om day 2 and the posttest data &om day 11 were 
examined. 
The conditioning scores in both experiments were defined by the 
number of minutes 
spent on the drug-conditioned compartment on posttest 
trial minus the number of 
minutes spent on the same compartment in the pretest trial. For each 
gender subset, 
subject weight was analyzed using a repeated measures ANOVA test with weekly body 
weight averages serving as the within factor. The behavioral 
data were analyzed by a 3 
doses of cocaine (0 mg/kg, 2. 5 mg/kg, 5 mg/kg) X 3 doses of MDMA (0 mg/kg, 5 
mg/kg, 10 mg/kg) X 2 gender (female, male) completely factorial 
ANOVA. T-tests 
between individual groups were used for post hoc analysis, Thus a 
total of 126 animals 
(N=l 8 groups, N=7/group) were required for this investigation. 
13 
RESULTS 
Results &om the three-way ANOVA indicate a significant interaction at the 
overall level, i. e. gender x MDMA x cocaine (F(4, 108)=3. 39, R&0. 05). A further 
interaction effect was revealed between MDMA and cocaine (F(4, 108)=6. 99, g&0. 001). 
The gender by MDMA interaction approached significance (F(2, 108)=2. 80, p=0. 065) 
[refer to figures 1 and 2]. 
Experiment 1: Male CPP 
In males, cocaine administered alone produced a clear dose-effect curve; 
significant differences &om saline were evident at both 2. 5 mg/kg and 5 mg/kg; p&0. 01. 
A biphasic effect was seen across the three MDMA doses in males; p&0. 01 when they 
were administered singularly, wherein reward properties increased at the medium dose 
(5 mg/kg MDMA) and diminished at the highest dose (10 mg/kg). The rewarding 
properties of 5 mg/kg MDMA presented alone were diminished by the addition of 
cocaine. Similarly, there was a reversal of the aversive properties of 10 mg/kg MDMA 
with the addition of cocaine. 
Male rats receiving 10 mg/kg MDMA injections showed increased excitation and 
ejaculation at the time of cocaine i. p. administration and placement within their non- 
preferred chamber for conditioning. These excitatory signs were not observed at the 5 
mg/kg or 0 mg/kg level of MDMA. 
Two male rats died on day 5 of the research project due to hyperthermia 
following conditioning runs with 5C — 10M and 2. 5C — 10M. A third male rat in the OC 
— 10M condition was detected showing symptoms of the early stages of hyperthermia 
(decreased muscle tone, non-responsiveness, rapid heart rate, shallow breathing, frothing 
at the mouth, and temporary paralysis). To quickly lower core body temperature, he was 
placed in a walk-in &eezer at 45'C for approximately 20 minutes. Within 10 minutes 
following cooling, the rat was responsive to nerve tests and breathing was more normal. 
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Within 30 minutes after having been placed in the &eezer, the rat was pulling hitnself 
around his home cage although his extremities remained unusable for several hours. 

Pj 
F= 
Results &om post hoc t-tests between individual groups of male rats are 
summarized in Tables 2 & 3. 
Table 21 Cocaine Dose in Males. Independent sample t-test on mean (+SEM) 
conditioning scores (measured in minutes) between 0 mg/kg, 5 mg/kg, and 10 mg/kg 
MDMA-exposed animals within their respective cocaine dose. Asterisks (*) indicate 
that the CPP conditioning scores between the two groups were significantly different (p 
& 0. 05). Double asterisks (**) indicate that differences in mean conditioning scores 
between two groups were significant (p&0. 01). 
Cocaine Dose Compared MDMA Doses (and mean CPP smres e SKM, mloutes) t Value Probability 
Omg/kg 0cocOmg/kg MDMA(017e077) &Ococ Smg/kg MDMA(519e045) t(12)=559 p«001»' 
0 coc-10 mg/kg MDMA (0. 09 e 0 65) & 0 coc-5 mg/kg MDMA (5. 19 e 0 45) t(12) 6. 41 p & 0 01»' 
2 5 mg/kg 2. 5 coc-0 mg/kg MDMA (2 00 e 0 45) & 2. 5 coc-5 mg/kg MDMA (4. 23 6 0 24) t(12) = 4 39 p & 0. 01*» 
2. 5 coc-10mg/kgMDMA (2 30e 0. 61) & 2. 5coc-5mg/kg MDMA(423 e024) t(12) =296 p& 0. 05 ~ 
Table 3: MDMA Dose in Males. Independent sample t-test on mean (+SEM) 
conditioning scores (measured in minutes) produced by 0 mg/kg, 2. 5 mg/kg, and 5 
mg/kg cocaine within their respective MDMA dose. Presence of an asterisk (*) 
indicates that mean conditioning scores between two groups were significantly different 
(p & 0. 05), and asterisks (o*) indicate that differences in mean conditioning scores 
between two groups were significant (p&0. 01) 
MDMA Dose Compared Cocaine Doses (and mean CPP score»a SKM, minutes) t Value Probabgity 
0 mg/kg 
5 mg/kg 
10 mg/kg 
0 coc -0 mg/kg MDMA(0. 17 e 0 77) & 2 5 coc -0 mg/kg MDMA (2 00 e 0. 45) 
0 coc -0 mg/kg MDMA (0 17 e 0. 77) & 5 coc -0 uat/kg MDMA (4 91 e 1. 72) 
5 coc -5 mg/kg MDMA(2. 10e0 37) & 0 coc -5 mg/kg MDMA(5. 19 a 045) 
Scoc-5mg/kgMDMA(2 toe037) &2 5 coc-5mg/kg MDMA(4 23e024) 
0 coc -1 0 mg/kg MDMA (0 09 e 0. 65) & 2. 5 coc -1 0 mg/kg MDMA (2 30+ 0. 60) 
0coc-10mg/kg MDMA(009 o 065) &5coc-10mg/kg MDMA(3 lge056) 
t(12) = 2. 05 
t(12) = 2 51 
t(12) = 5 27 
t(12) = 4 78 
t(12) = 2. 48 
t(12) 3, 59 
p = 0. 06 
p & 0. 05» 
p&001" 
p & 0 01»» 
p& 005» 
p &001»» 
Thus, for males, individual comparisons indicated that at the 0 mg/kg cocaine 
dose, group differences existed between 0 coc — 0 MDMA and 0 coc — 5 MDMA 
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(p&0. 01) as well as between 0 coc — 10 MDMA and 0 coc — 5 MDMA (p&0. 01). At the 
2. 5 mg/kg cocaine dose, group differences existed between 2. 5 coc — 0 MDMA and 2. 5 
coc — 5 MDMA (p&0. 01) as well as between 2. 5 coc — 10 MDMA and 2. 5 coc — 5 
MDMA (p&0. 05). Individual comparisons indicated that at the 0 mg/kg MDMA dose, 
group differences existed between 0 coc — 0 MDMA and 2. 5 coc — 0 MDMA (p&0. 05). 
At the 5 mg/kg MDMA dose, group differences existed between 0 coc — 0 MDMA and 5 
coc — 0 MDMA (p&0. 01) as well as between 5 coc — 5 MDMA and 2. 5 coc — 5 MDMA 
(p&0. 01). At the 10 mg/kg MDMA dose, group differences existed between 0 coc — 10 
MDMA and 2. 5 coc — 10 MDMA (p&0. 05) as well as between 0 coc — 10 MDMA and 5 
coc — 10 MDMA (p&0. 01). 
Experiment 2: Female CPP 
Females, like males, showed a dose-effect curve with cocaine exposure wherein 
the highest dose of cocaine produced more rewarding effects and heightened CPP (see 
figures 3 and 4). Although not rewarding alone, 5 rng/kg MDMA did produce an 
enhanced place preference in combination with a low level of cocaine (p&0. 05), which 
was reversed in combination with a high level of cocaine. Although the 10 mg/kg 
MDMA presentation was highly rewarding to females, when in combination with 5 
mg/kg cocaine (which was also rewarding when presented alone), this level of MDMA 
becomes aversive. 
Reported trends for female subjects are collapsed across estrus cycle to depict 
overall female performance. Estrus, however, is suspected to be responsible, at least in 
part, for the high variance in conditioning. Upon completion of testing, 19 female rats 
(approximately 1/3) were determined to be in estrous, as determined with vaginal lavage. 
The other 44 female rats were either in proestrus, diestrus, or meta-estrus on their final 
testing day. 
During experimentation with females, no animals died from complications with 
hyperthermia and only one rat developed hyperthermic symptoms (see above), including 
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eye and nose bleeds. One rat was discovered with hyperthermia on days 7 and 9 (both 
drug conditioning days). On day 7, she was limp and nonresponsive when taken out of 
the CPP chamber. She was irnrnediately placed in a 45'C walk-in type freezer and 
remained there approximately 40 minutes. Approximately 1 hour atter cooling core 
body temperature, the rat was able to stand independently, was more responsive, and had 
regained slight motility. On day 9 of the experiment (final day of drug conditioning), the 
same animal displayed extreme hyperactivity upon completion of the 20-minute 
conditioning session. Within 5 to 10 minutes of returning to its homecage, the animal 
once again had developed symptoms of hyperthermia and was cooled for 30 minutes. 
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Results fiom post hoc t-tests between individual groups of female rats are 
summarized in Tables 4 86 5. 
Table 4: Cocaine Dose in Females. Independent sample t-test on mean (+SEM) 
conditioning scores (measured in minutes) between 0 mg/kg, 5 mg/kg, and 10 mg/kg 
MDMA-exposed animals within their respective cocaine dose. Asterisks (*) indicate 
that the CPP conditioning scores between the two groups were significantly different (p 
& 0. 05). Double asterisks (un) indicate that differences in mean conditioning scores 
between two groups were significant (p&0. 01). 
Cocaine Dose Compared MDMA Doses (and mean CPP scores a SEM, minutes) t Value Probability 
0mg/kg 0 coc-0 mb kg MDMA (0 059 a 1 99) & 0 cue-10 mg/kg MDMA (5. 904 1, 99) t(12) 2, 36 p & 0, 05* 
2. 5 mg/kg 2 5 coc4) mg/kg MDMA (0. 80 e 1. 01) & 2 5 coc-5 mg/kg MDMA (5. 04 + 1 25) t(12) = 2 64 p & 0. 05» 
2. 5 coc-0 mg/kg MDMA 0. 80 4 1 01) & 2. 5 coc-10 mg/kg MDMA (5. 28 e 0. 92) t(12) = 3 29 p & 0. 01»» 
Table 5: MDMA Dose in Females. Independent sample t-test on mean (+SEM) 
conditioning scores (measured in minutes) produced by 0 mg/kg, 2. 5 mg/kg, and 5 
mg/kg cocaine within their respective MDMA dose. Presence of an asterisk (*) 
indicates that mean conditioning scores between two groups were significantly different 
(p & 0. 05). 
MDMA Dose Compared Cocaine Doses (and mean CPP scores e SEM, mlautes) t Value Probability 
10 mg/kg 5 coc-10 mg/kg MDMA (0. 74 e 1 64) & 0 coc-10 mg/kg MDMA (5 90 4 1 47) t(12) = 2 34 p & 0 05» 
5 coc-10mg/kg MDMA(0 74 e 1 64) & 2 5 coc-10mg/kg MDMA(5 28+ 092) t(12) = 242 p & 0 05» 
Thus, for females, individual comparisons indicated that at the 0 mg/kg cocaine 
dose, group differences existed between 0 coc — 0 MDMA and 0 coc — 10 MDMA 
(p&0. 05). At the 2. 5 mg/kg cocaine dose, group differences existed between 2. 5 coc — 0 
MDMA snd 2. 5 coc — 5 MDMA (p&0. 05) as well as between 2. 5 coc — 0 MDMA and 
2. 5 coc — 10 MDMA (p&0. 01). Individual comparisons indicated that at the 10 mg/kg 
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MDMA dose, group differences existed between 5 coc — 10 MDMA and 0 coc — 10 
MDMA (p&0. 05) as well as between 5 coc — 10 MDMA and 2. 5 coc — 10 MDMA 
(p&0. 05). 
Gender Differences 
Also notable is the difference between males and females at the 10 mg/kg dose of 
MDMA (see Table 6). Whereas males showed aversion to single administrations of the 
drug and increased preference when paired with cocaine, females showed a preference of 
single administration of 10 mg/kg MDMA and decreased preference when paired with 
cocaine. Females seemed to express a shift right in the dose-effect curve (decreased 
senstitivity) for MDMA (e. g. , while 10 mg/kg MDMA alone is aversive to males, it is 
not aversive to females until combined with 5 mg/kg cocaine). 
Table 6: Gender Differences. Independent sample t-test on mean (+SEM) conditioning 
scores (measured in minutes) between gender within their respective drug dose. A plus 
sign (+) indicates that the CPP conditioning scores between the two groups were 
significantly different (p & 0. 05). Double plus signs (++) indicate that differences in 
mean conditioning scores between two gmups were significant (p&0. 01). 
Drllg Dose Compared Gender (and mean Cpp scores a SEM, mlantes) t Valse Probabgtty 
0 coc-5 mg/kg MDMA Female(2, 65+082) &Male(5194045) 
0 coc-10 mglkg MDMA Male (0. 09 4 0. 65) & Female (5 904 1. 47) 
i(12)=271 p&005+ 
t(12) = 3. 60 p & 0 01++ 
Thus, individual comparisons indicated that at the 0 coc — 5 MDMA dose, group 
differences existed between males and females (p&0. 05). At the 0 coc — 10 MDMA 
dose, group differences existed between males and females (p&0. 01). 
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DISCUSSION 
Experiment 1: Male CPP 
In males, a clear and significant place preference for cocaine was demonstrated 
between 0 mg/kg, 2. 5 mg/kg, and 5 mg/kg cocaine combined with 0 mg/kg MDMA. 
The rewarding properties of cocaine at these doses has been well demonstrated and is 
consistent with our findings (Busse et al. , 2003). Increases in cocaine dose modulate 
neural reward mechanisins through the dopamine system. The reward value of 5 mg/kg 
MDMA presented singularly produced a significant CPP similar to what was produced 
by Smg/kg cocaine alone. The combination of a highly rewarding dose of MDMA (5 
mg/kg) with a moderately rewarding dose of cocaine (2. 5 mg/kg) actually starts to 
become less rewarding. The most rewarding doses of MDMA (5 mg/kg) and cocaine (5 
mg/kg) produce the highest levels of CPP when presented separately, yet when 
combined actually become significantly more aversive. This is in opposition to the 
rationale that formed the basis for our research, i. e. that the combination of the 
rewarding drugs would actually produce an even greater reward neurochemically and a 
more pronounced place preference. Ostensibly, in combination these highly rewarding 
drugs appear to actually become aversive. The aversive properties of MDMA may be in 
effect more prevalently at higher doses. Male rats showed no CPP for 10 mg/kg 
MDMA. Experimentation with MDMA is Irequently done at the 10 mg/kg dose and has 
shown to induce CPP similar to saline even in adolescent subjects (Achat-Mendes, C. 
2003), and MDMA at 20 mg/kg is considered neurotoxic. 10 mg/kg MDMA is not 
neumtoxic enough entirely deplete drug-reward systems, which allows a resurgence of 
reward-conditioning when this dose is paired with rewarding doses of cocaine. 
While cocaine at these levels show a linear relationship between dose and 
reward, MDMA at these levels depicts a biphasic effect wherein low doses are highly 
rewarding and higher doses are more aversive. When these drugs are combined, the 
properties of one drug antagonize the rewarding or aversive properties of the other. A 
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possible explanation for this phenomenon may rest with a cubic function which may 
characterize the interactive effects of the two commonly abused drugs. That is, 
relatively small drug doses possess rewarding characteristics. As the potency of the drug 
increases or larger doses are administered the aversive properties of the drug cause a 
downward shift in CPP, as rewarding effects are lost or eclipsed by more aversive drug 
effects. The cubic trend proposes that pushing past the aversiveness of high drug doses 
with exceptionally potent doses may once again stimulate neural reward mechanisms 
(perhaps by potentiating change in secondary or alternate reward systems). 
Excepuonally high doses of a single drug or synergistic effects in poly-drug conditions 
may show reward agonism, however, such strong drug dosages or multiple drug 
combinations are typically associated with high rates of lethality and thus are 
contraindicated. 
Consistent with the theory of a cubic trend of poly-drug effect elicited by 
concurrent combinations of cocaine and MDMA, what would initially be on the 
ascending limb of a cubic-dose-effect curve would be altered unidirectionally by 
increases in drug dose (see figure 5). 
The addition of cocaine antagonizes (offsets) the biphasic effect produced by 
MDMA. Although MDMA at 5 mg/kg is even more rewarding than the highest dose of 
cocaine (10 mg/kg), the highly rewarding effects are progressively decreased as the 
amount of added cocaine is increased. Inversely, although MDMA at 10 mg/kg is 
aversive, it becomes increasingly more rewarding in combination with high doses of 
cocaine. Whereas cocaine is highly rewarding at the 5 mg/kg level, subsequent pairings 
with higher levels of MDMA result in significantly decreased conditioned place 
preference. 
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Figure 5: Cubic trend for males. Short arrows denote change in CPP with increase 
from 0 MDMA to 5 MDMA. Long arrows denote change in CPP with increase fiom 0 
MDMA to 10 MDMA. 
The reversal by high doses of cocaine of the aversive properties of 10mg/kg 
MDMA is explained by a cubic trend with respect to defining the character of 
cocaine/MDMA interactions (refer to figure 5). The interactive effects of the drug hint 
at enhanced reward properties with increasing drug dose above the aversive level. 
Experiment 2: Female CPP 
Reported trends for female subjects are collapsed across estrus cycle to depict 
overall female performance. Estrus, however, is suspected to be responsible, at least in 
part, for the high variance in conditioning. Estrus has traditionally been noted to cause 
alterations in drug sensitivity at both the animal and human level (Sell et al. , 2000). 
Previous studies have shown that estrous enhances cocaine sensitivity and creates a shift 
in the dose-response curve for cocaine (Bowman & Kuhn, 1996; Chen et al. , 2003; Zhou 
et al. , 2003). Females show a decreased sensitivity to MDMA and cocaine relative to 
males and show large variance due to esmts cycles. Estrus has traditionally been noted 
to cause alterations in drug sensitivity at both the animal and human level. Previous 
studies have shown that estrous enhances cocaine sensitivity and creates a shift in the 
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dose-response curve for cocaine (Bowman k Kuhn, 1996; Chen et al. , 2003; Zhou et al. , 
2003). 
Females exhibit a dose-dependent cocaine reward effect. MDMA's ability to 
reverse those effects are delayed (i. e. , a higher MDMA dose is required to offset the 
reward properties associated with cocaine use). MDMA at the 10 mg/kg level is still 
highly rewarding (whereas MDMA at the 5 mg/kg level was most rewarding in males). 
Decreased sensitivity in females would thus require higher drug levels to achieve the 
same behavioral effects, whether rewarding or aversive. Similarly, while 10 mg/kg 
MDMA alone is aversive in males, this high dose of MDMA must be combined with 5 
mg/kg coc before this aversiveness is seen in females. 
Aversiveness from each drug's hyperthermic effect may also be one of the 
underlying reasons for the reduction in preference at 5 mg/kg MDMA with subsequent 
pairings of cocaine. 
Conclusions 
Our results show that cocaine and MDMA do interact, but in an antagonistic 
fashion, rather than a synergistic one. These findings could provide insight to deeper 
understanding of the interactive effects of combining drugs of abuse as well as provide 
new insight and potential therapeutic strategies for drug dependence in men and women. 
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